WellPoint Singulair coverage

Use of Merck's Singulair (montelukast) solely for allergies will require prior authorization, WellPoint says. Use for asthma does not require prior authorization. Contrary to Merck's suggestion that Singulair would be fully covered for both asthma and allergies due to managed care's inability to determine the specific indication, WellPoint said it will distinguish indications by checking patient records for concomitant beta agonist use (1"The Pink Sheet" Jan. 6, p. 7)...